{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:11Z","timestamp":1790937071158,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150748","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:36:30Z","timestamp":1727300190000},"page":"150748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["SERCA pump as a novel therapeutic target for treating neurodegenerative disorders"],"prefix":"10.1016","volume":"734","author":[{"given":"Russell","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Bezprozvanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150748_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.150748_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001694","article-title":"If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?","volume":"20","author":"Haass","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2024.150748_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150748_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150748_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2022.08.075","article-title":"Alzheimer's disease - where do we go from here?","volume":"633","author":"Bezprozvanny","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150748_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120861","article-title":"Alzheimer's disease failed clinical trials","volume":"306","author":"Asher","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/jama.2023.11701","article-title":"Ushering in a new era of alzheimer disease therapy","volume":"330","author":"Widera","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2024.150748_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1399121","article-title":"Alzheimer's disease and its treatment-yesterday, today, and tomorrow","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150748_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-220264","article-title":"Making the case for the accelerated withdrawal of aducanumab","volume":"87","author":"Whitehouse","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bbrc.2024.150748_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054367","article-title":"Aducanumab-hope or disappointment for alzheimer's disease","volume":"24","author":"Wojtunik-Kulesza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-023-01331-1","article-title":"Lecanemab: more questions than answers","volume":"44","author":"Kaur","year":"2024","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.bbrc.2024.150748_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/09727531221136349","article-title":"Future of monoclonal antibody therapy in Parkinson's disease","volume":"30","author":"Kharel","year":"2023","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150748_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 Years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbrc.2024.150748_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","article-title":"Double setback for ASO trials in Huntington disease","volume":"20","author":"Kingwell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.150748_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2024.150748_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molmed.2009.01.001","article-title":"Calcium signaling and neurodegenerative diseases","volume":"15","author":"Bezprozvanny","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150748_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1989.tb12485.x","article-title":"Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview","volume":"568","author":"Khachaturian","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/157015911798376316","article-title":"A role for calcineurin in Alzheimer's disease","volume":"9","author":"Reese","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2024.150748_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052056","article-title":"Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease","volume":"7","author":"Chakroborty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150748_bib20","article-title":"Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures","author":"Chakroborty","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150748_bib21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ncomms2149","article-title":"CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease","volume":"3","author":"Kang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150748_bib22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s13311-019-00777-6","article-title":"Molecular mechanisms and therapeutics for spinocerebellar ataxia type 2","volume":"16","author":"Egorova","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrc.2024.150748_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/life13051187","article-title":"\"Dirty dancing\" of calcium and autophagy in alzheimer's disease","volume":"13","author":"Zhang","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.bbrc.2024.150748_bib24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s11064-010-0393-y","article-title":"Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias","volume":"36","author":"Bezprozvanny","year":"2011","journal-title":"Neurochem. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2024.150748_bib25","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1080\/14660820152415744","article-title":"Calcium: the darth vader of ALS","volume":"2","author":"Appel","year":"2001","journal-title":"Amyotroph Lateral Scler."},{"key":"10.1016\/j.bbrc.2024.150748_bib26","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","article-title":"Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of alzheimer disease","volume":"32","author":"Oules","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150748_bib27","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1523\/JNEUROSCI.0739-06.2006","article-title":"Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice","volume":"26","author":"Stutzmann","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150748_bib28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1523\/JNEUROSCI.1820-22.2022","article-title":"A gating mutation in ryanodine receptor type 2 rescues phenotypes of alzheimer's disease mouse models by upregulating neuronal autophagy","volume":"43","author":"Zhang","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150748_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-150065","article-title":"Reduced incidence of dementia in solid organ transplant patients treated with calcineurin inhibitors","volume":"47","author":"Taglialatela","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bbrc.2024.150748_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"Isradipine versus placebo in early Parkinson disease: a randomized trial","volume":"172","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2024.150748_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2019.10.016","article-title":"Calcium hypothesis of neurodegeneration - an update","volume":"520","author":"Bezprozvanny","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150748_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/acn3.51300","article-title":"Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's disease","volume":"8","author":"Venuto","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.bbrc.2024.150748_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/scdb.2000.0211","article-title":"Calcium signalling--an overview","volume":"12","author":"Bootman","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2024.150748_bib34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/cphy.c110034","article-title":"Calcium pumps: why so many?","volume":"2","author":"Brini","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2024.150748_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168891","article-title":"Nothing regular about the regulins: distinct functional properties of SERCA transmembrane peptide regulatory subunits","volume":"22","author":"Rathod","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2015.01.009","article-title":"A micropeptide encoded by a putative long noncoding RNA regulates muscle performance","volume":"160","author":"Anderson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150748_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.aad4076","article-title":"A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150748_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaj1460","article-title":"Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides","volume":"9","author":"Anderson","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2024.150748_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-030-12457-1_6","article-title":"A role for SERCA pumps in the neurobiology of neuropsychiatric and neurodegenerative disorders","volume":"1131","author":"Britzolaki","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2024.150748_bib40","doi-asserted-by":"crossref","first-page":"18533","DOI":"10.1073\/pnas.0906797106","article-title":"Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump","volume":"106","author":"Vandecaetsbeek","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150748_bib41","article-title":"Cryo-EM structures of SERCA2b reveal the mechanism of regulation by the luminal extension tail","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2024.150748_bib42","doi-asserted-by":"crossref","first-page":"47877","DOI":"10.1074\/jbc.M306784200","article-title":"Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses","volume":"278","author":"Dode","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150748_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1087057112456878","article-title":"High-throughput FRET assay yields allosteric SERCA activators","volume":"18","author":"Cornea","year":"2013","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.bbrc.2024.150748_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1087057113510740","article-title":"Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells","volume":"19","author":"Gruber","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.bbrc.2024.150748_bib45","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1021\/jm030830y","article-title":"Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds","volume":"46","author":"De Munari","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.150748_bib46","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.bmcl.2018.03.052","article-title":"A new target for Alzheimer's disease: a small molecule SERCA activator is neuroprotective in vitro and improves memory and cognition in APP\/PS1 mice","volume":"28","author":"Krajnak","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2024.150748_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bmc.2016.10.008","article-title":"A new target for Parkinson's disease: small molecule SERCA activator CDN1163 ameliorates dyskinesia in 6-OHDA-lesioned rats","volume":"25","author":"Dahl","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.150748_bib48","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1074\/jbc.M115.705012","article-title":"Small molecular allosteric activator of the sarco\/endoplasmic reticulum Ca2+-ATPase (SERCA) attenuates diabetes and metabolic disorders","volume":"291","author":"Kang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150748_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/ci00053a005","article-title":"Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions","volume":"27","author":"Ghose","year":"1987","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib50","article-title":"Mechanisms for cardiac calcium pump activation by its substrate and a synthetic allosteric modulator using fluorescence lifetime imaging","volume":"3","author":"Seflova","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.bbrc.2024.150748_bib51","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/cmdc.202100350","article-title":"Stimulation of Ca(2+) -ATPase transport activity by a small-molecule drug","volume":"16","author":"Sordi","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbrc.2024.150748_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65545","article-title":"Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA","volume":"10","author":"Fisher","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2024.150748_bib53","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/acschembio.9b00399","article-title":"CETSA beyond soluble targets: a broad application to multipass transmembrane proteins","volume":"14","author":"Kawatkar","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2024.150748_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.str.2021.11.003","article-title":"A kink in DWORF helical structure controls the activation of the sarcoplasmic reticulum Ca(2+)-ATPase","volume":"30","author":"Reddy","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2024.150748_bib55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41420-024-02047-7","article-title":"Heat stress induces calcium dyshomeostasis to subsequent cognitive impairment through ERS-mediated apoptosis via SERCA\/PERK\/eIF2alpha pathway","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2024.150748_bib56","article-title":"Restoration of sarco\/endoplasmic reticulum Ca(2+)-ATPase activity functions as a pivotal therapeutic target of anti-glutamate-induced excitotoxicity to attenuate endoplasmic reticulum Ca(2+) depletion","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150748_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13382","article-title":"Involvement of nucleus accumbens SERCA2b in methamphetamine-induced conditioned place preference","volume":"29","author":"Wang","year":"2024","journal-title":"Addiction Biol."},{"key":"10.1016\/j.bbrc.2024.150748_bib58","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/ps.8040","article-title":"Establishment and evaluation of targeted molecular screening model for the ryanodine receptor or sarco\/endoplasmic reticulum calcium ATPase","volume":"80","author":"Lu","year":"2024","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091354","article-title":"The effect of SERCA activation on functional characteristics and signaling of rat soleus muscle upon 7 Days of unloading","volume":"13","author":"Sharlo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2024.150748_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010037","article-title":"Restoration of sarcoplasmic reticulum Ca(2+) ATPase (SERCA) activity prevents age-related muscle atrophy and weakness in mice","volume":"22","author":"Qaisar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.redox.2018.09.018","article-title":"Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness","volume":"20","author":"Qaisar","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2024.150748_bib62","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddab100","article-title":"Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice","volume":"30","author":"Nogami","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2024.150748_bib63","article-title":"Cadmium disrupted ER Ca(2+) homeostasis by inhibiting SERCA2 expression and activity to induce apoptosis in renal proximal tubular cells","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib64","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1111\/bph.16160","article-title":"CDN1163, an activator of sarco\/endoplasmic reticulum Ca(2+) ATPase, up-regulates mitochondrial functions and protects against lipotoxicity in pancreatic beta-cells","volume":"180","author":"Nguyen","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150748_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2021.112690","article-title":"Neonicotinoid insecticides triggers mitochondrial bioenergetic dysfunction via manipulating ROS-calcium influx pathway in the liver","volume":"224","author":"Li","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bbrc.2024.150748_bib66","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201272R","article-title":"Acute activation of SERCA with CDN1163 attenuates IgE-mediated mast cell activation through selective impairment of ROS and p38 signaling","volume":"37","author":"Hunter","year":"2023","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2024.150748_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166152","article-title":"Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease","volume":"1867","author":"Solana-Manrique","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2024.150748_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311057","article-title":"Positive allosteric modulator of SERCA pump NDC-1173 exerts beneficial effects in mouse model of alzheimer's disease","volume":"24","author":"Dahl","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813973","article-title":"Positive allosteric modulators of SERCA pump restore dendritic spines and rescue long-term potentiation defects in alzheimer's disease mouse model","volume":"24","author":"Rakovskaya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150748_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112984","article-title":"Chronic but not acute pharmacological activation of SERCA induces behavioral and neurochemical effects in male and female mice","volume":"399","author":"Britzolaki","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbrc.2024.150748_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/FBP.0000000000000756","article-title":"Chronic pharmacological activation of SERCA with CDN1163 affects spatial cognitive flexibility but not attention and impulsivity in mice","volume":"34","author":"Klocke","year":"2023","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150748_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.bbrc.2024.150748_bib73","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:33:08Z","timestamp":1732631588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24012841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":73,"alternative-id":["S0006291X24012841"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150748","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SERCA pump as a novel therapeutic target for treating neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150748"}}